Momentum mover, Rosetta Genomics Ltd. (NASDAQ: ROSG) announced data from studies of miRview mets in patients with Cancer of Unknown ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE